Back to Results
First PageMeta Content
Pharmacology / Clinical research / Drug safety / BSE Sensex / Ranbaxy Laboratories / New Drug Application / Food and Drug Administration / Pharmaceutical sciences / Pharmaceutical industry


Case 1:12-cv[removed]JFM Document 2 Filed[removed]Page 1 of 58 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MARYLAND UNITED STATES OF AMERICA, Plaintiff,
Add to Reading List

Document Date: 2012-01-25 22:13:38

Open Document

File Size: 314,59 KB

Share Result on Facebook

City

Princeton / Nawanshahar / Dewas / Mohali / Gurgaon / North Brunswick / Gloversville / Himanchal Pradesh / New Brunswick / /

Company

Ohm Laboratories / Defendant Ranbaxy Laboratories Ltd. / Corporate Defendants / Daiichi Sankyo Co. Ltd. / Phase III Ind. / RANBAXY LABORATORIES LTD. / RANBAXY INC. / /

Continent

America / /

Country

United States / India / /

Event

Product Issues / Product Recall / FDA Phase / /

Facility

Terminal Road / India facility / /

IndustryTerm

manufacturing drugs / manufacturing practice requirements / manufacturing / active pharmaceutical ingredients / manufacturing process / /

Organization

Food and Drug Administration / UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MARYLAND UNITED STATES OF AMERICA / office of Data Reliability / /

Person

Venkatachalam Krishnan / ARUN SAWHNEY / DALE ADKISSON / /

Position

Director Americas / Director to the Managing / President / Managing Director / Vice President / Head Global Quality / Chief Data Reliability Officer / Data Quality Auditor / Regional Director / /

Product

Batamandi NDAs / NDAs / approval / A41 / United States / /

ProvinceOrState

Punjab / New Jersey / Quebec / New Brunswick / Sirmour District / New York / /

SocialTag